Inhibition of transcription factor NF-κB in the central nervous system ameliorates autoimmune encephalomyelitis in mice

Nature Immunology

Volumn 7, Issue 9, 2006, Pages 954-961

  van Loo, Geert ^a   De Lorenzi, Rossana ^a   Schmidt, Hauke ^b   Huth, Marion ^a   Mildner, Alexander ^b   Schmidt Supprian, Marc ^c   Lassmann, Hans ^d   Prinz, Marco R ^b   Pasparakis, Manolis ^a,e  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF VIENNA   (Austria)

^e UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CCL4 CHEMOKINE; CHEMOKINE; CXCL9 CHEMOKINE; FAS LIGAND; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 5; RANTES; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; GENE EXPRESSION; IMMUNOPATHOGENESIS; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MALE; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUE INJURY;

ANIMALS; ASTROCYTES; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE DELETION; GENE EXPRESSION REGULATION; I-KAPPA B KINASE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, TRANSGENIC; MICROGLIA; MULTIPLE SCLEROSIS; NF-KAPPA B; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33747609345     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1372     Document Type: Article

References (45)

1. Steinman, L. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system. Cell 85, 299-302 (1996).
2. Steinman, L. Multiple sclerosis: A two-stage disease. Nat. Immunol. 2, 762-764 (2001).
3. Hafler, D.A. Multiple sclerosis. J. Clin. Invest. 113, 788-794 (2004).
4. Hemmer, B., Archelos, J.J. & Hartung, H.P. New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci. 3, 291-301 (2002).
5. Gerard, C. & Rollins, B.J. Chemokines and disease. Nat. Immunol. 2, 108-115 (2001).
6. Huang, D. et al. Chemokines and chemokine receptors in inflammation of the nervous system: Manifold roles and exquisite regulation. Immunol. Rev. 177, 52-67 (2000).
7. Fife, B.T., Huffnagle, G.B., Kuziel, W.A. & Karpus, W.J. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 192, 899-905 (2000).
8. Izikson, L., Klein, R.S., Charo, I.F., Weiner, H.L. & Luster, A.D. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J. Exp. Med. 192, 1075-1080 (2000).
9. Ransohoff, R.M. The chemokine system in neuroinflammation: An update. J. Infect. Dis. 186, S152-S156 (2002).
10. Lock, C. et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmume encephalomyelitis. Nat. Med. 8, 500-508 (2002).
11. Ibrahim, S.M. et al. Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis. Brain 124, 1927-1938 (2001).
12. Heppner, F.L. et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 11, 146-152 (2005).
13. Greter, M. et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11, 328-334 (2005).
14. McMahon, E.J., Bailey, S.L., Castenada, C.V., Waldner, H. & Miller, S.D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11, 335-339 (2005).
15. De Keyser, J., Zeinstra, E. & Frohman, E. Are astrocytes central players in the pathophysiology of multiple sclerosis? Arch. Neurol. 60, 132-136 (2003).
16. Ridet, J.L., Malhotra, S.K., Privat, A. & Gage, F.H. Reactive astrocytes: Cellular and molecular cues to biological function. Trends Neurosci. 20, 570-577 (1997).
17. Volterra, A. & Meldolesi, J. Astrocytes, from brain glue to communication elements: The revolution continues. Nat. Rev. Neurosci. 6, 626-640 (2005).
18. Mattson, M.P. & Camandola, S. NF-κB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107, 247-254 (2001).
19. Hilliard, B., Samoilova, E.B., Liu, T.S., Rostami, A. & Chen, Y. Experimental autoimmune encephalomyelitis in NF-κB-deficient mice:rOles of NF-κB in the activation and differentiation of autoreactive T cells. J. Immunol. 163, 2937-2943 (1999).
20. Hilliard, B.A. et al. Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. J. Clin. Invest. 110, 843-850 (2002).
21. Dasgupta, S. et al. Antineuroinflammatory effect of NF-κB essential modifier-binding domain peptides in the adoptive transfer model of experimental allergic encephalomyelitis. J. Immunol. 173, 1344-1354 (2004).
22. Karin, M. & Lin, A. NF-κB at the crossroads of life and death. Nat. Immunol. 3, 221-227 (2002).
23. Ghosh, S. & Karin, M. Missing pieces in the NF-κB puzzle. Cell 109, S81-S96 (2002).
24. Lawrence, T., Bebien, M., Liu, G.Y., Nizet, V. & Karin. M. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 434, 1138-1143 (2005).
25. Pasparakis, M. et al. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417, 861-866 (2002).
26. Schmidt-Supprian, M. et al. NEMO/IKK-γ-deficient mice model incontinentia pigmenti. Mol. Cell 5, 981-992 (2000).
27. Tronche, F. et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23, 99-103 (1999).
28. 1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex. Neuron 31, 367-379 (2001).
29. Iademarco, M.F., McQuillan, J.J., Rosen, G.D. & Dean, D.C. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J. Biol. Chem. 267, 16323-16329 (1992).
30. Osborn, L. et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59, 1203-1211 (1989).
31. Carlos, T.M. et al. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood 76, 965-970 (1990).
32. Rosenman, S.J., Shrikant, P., Dubb, L., Benveniste, E.N. & Ransohoff, R.M. Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. J. Immunol. 154, 1888-1899 (1995).
33. 7-integrin. J. Clin. Invest. 102, 2096-2105 (1998).
34. Gimenez, M.A., Sim, J.E. & Russell, J.H. TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammation. J. Neuroimmunol. 151, 116-125 (2004).
35. Priller, J. et al. Targeting gene-modified hematopoietic cells to the central nervous system: Use of green fluorescent protein uncovers microglial engraftment. Nat. Med. 7, 1356-1361 (2001).
36. Perry, V.H. & Gordon, S. Macrophages and microglia in the nervous system. Trends Neurosci. 11, 273-277 (1988).
37. Hanisch, U.K. Microglia as a source and target of cytokines. Glia 40, 140-155 (2002).
38. Bechmann, I. et al. Astrocyte-induced T cell elimination is CD95 ligand dependent. J. Neuroimmunol. 132, 60-65 (2002).
39. Kwon, D., Cheong, J.H., Lee, J.C., Kwon, J.H. & Kim, W.K. Lipopolysaccharides-activated human astroglioma cells induce apoptotic death of T-lymphocytes via c-Jun N-terminal kinases-dependent up-regulation of TRAIL. Neurosci. Res. 54, 338-343 (2006).
40. Brambilla, R. et al. Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med, 202, 145-156 (2005).
41. Bonetti, B. et al. Activation of NF-κB and c-jun transcription factors in multiple sclerosis lesions. Implications for oligodendrocyte pathology. Am. J. Pathol. 155, 1433-1438 (1999).
42. Kontgen, F., Suss, G., Stewart, C., Steinmetz, M. & Bluethmann, H. Targeted disruption of the MHC class II Aa gone in C57BL/6 mice. Int. Immunol. 5, 957-964 (1993).
43. Prinz, M. et al. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Invest. 116, 456-464 (2006).
44. McCarthy, K.D. & de Vellis, J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85, 890-902 (1980).
45. Prinz, M. & Hanisch, U.K. Murine microglial cells produce and respond to interleukin-18. J. Neurochem. 72, 2215-2218 (1999).